Lead sponsor
Ali Aminian
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
3
Active
345
Total enrollment
22
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
3
Trials by status
Not yet recruiting
1
Recruiting
1
Active, not recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment